<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00282659</url>
  </required_header>
  <id_info>
    <org_study_id>WHIT001799HI</org_study_id>
    <nct_id>NCT00282659</nct_id>
  </id_info>
  <brief_title>The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control</brief_title>
  <official_title>The Use of Magnesium to Improve Hemodynamics, Cholesterol, and Glucose Control: A Substudy of AdMag</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hartford Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hartford Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if magnesium can improve blood pressure,
      cholesterol, and blood sugar control in patients with implantable cardioverter defibrillators
      (ICDs).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnesium is the second most abundant intracellular cation and plays a vital role in many
      physiologic processes. It has been determined that patients with cardiovascular disease have
      intracellular magnesium (Mgi) deficiencies. Among the ICD registries in Europe and the United
      States 64% and 77% of patients also carry the diagnosis of CAD, respectively. Patients with
      CAD have risk factors that lead to the development and or propagation of atherosclerosis.
      Paramount among these risk factors are hypertension, dyslipidemia, and diabetes.

      Comparison: Magnesium compared to placebo in patients with ICDs to evaluate the effect they
      have on cholesterol, blood pressure, and blood glucose.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <completion_date type="Anticipated">June 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure, cardiac output, systemic vascular resistance, thoracic fluid content, total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, and blood glucose</measure>
    <time_frame>at baseline, 3, and 6 months of follow-up</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Hypertension</condition>
  <condition>Dyslipidemia</condition>
  <condition>Diabetes</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>magnesium L-lactate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly implanted ICD or recent ICD shock (within 6 months)

        Exclusion Criteria:

          -  Inability to swallow

          -  A non-cardiac disease with a survival prognosis of less than 12 months

          -  Hypermagnesemia

          -  Creatinine clearance less than 30mL/min

          -  Lactic acidosis or systemic acidosis syndrome

          -  Previous intolerance to magnesium L-lactate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles M White, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Connecticut School of Pharmacy, Hartford Hospital Division of Drug Information</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charles M White, PharmD</last_name>
    <phone>860-545-2221</phone>
    <email>Cmwhite@harthosp.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeffrey Kluger, MD</last_name>
    <phone>860-545-2883</phone>
    <email>Jkluger@harthosp.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102-5037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles M White, PharmD</last_name>
      <phone>860-545-2221</phone>
      <email>Cmwhite@harthosp.org</email>
    </contact>
    <contact_backup>
      <last_name>Jeffrey Kluger, MD</last_name>
      <phone>860-545-2883</phone>
      <email>Jkluger@harthosp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Charles M White, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Kluger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nickole N Henyan, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen D Sander, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Effie L Gillespie, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher A Clyne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Craig I Coleman, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2006</study_first_submitted>
  <study_first_submitted_qc>January 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2006</study_first_posted>
  <last_update_submitted>November 2, 2007</last_update_submitted>
  <last_update_submitted_qc>November 2, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2007</last_update_posted>
  <keyword>Hemodynamics</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Implantable Cardioverter Defibrillator</keyword>
  <keyword>Blood Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

